December 2018 - Volume 2 - Issue 6

  • Jan Cools, Andreas Engert
  • 2572-9241
  • 2572-9241
  • Bimonthly
Latest Articles

Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines

by Hagenbeek, Anton; Engert, Andreas; Kapitein, Peter; Doeswijk, Robin; On behalf of the EHA Task Force on Fair Pricing

View All

Highlights of the Current Issue

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet

Itzykson, Raphael; Fenaux, Pierre; Bowen, David; More

HemaSphere. 2(6):e150, December 2018.

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML

Schwarer, Anthony P.; Butler, Jason; Jackson, Kathryn; More

HemaSphere. 2(6):e158, December 2018.

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?

Papalexandri, Apostolia; Saloum, Riad; Touloumenidou, Tasoula; More

HemaSphere. 2(6):e157, December 2018.